STOCK TITAN

Ani Pharmaceutic (ANIP) Net Income by Year

ANIP

Ani Pharmaceutic reported $78.0M in net income in fiscal year 2025. This represents an increase of 510.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $108.0M in net income. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Ani Pharmaceutic has filed alongside them.

FY2025 annual
Net Income $78.0M
YoY +510.5%
10Y CAGR +17.6%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ANIP Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income$108.0M$78.0M+510.5%-$19.0M-200.0%$19.0M+139.6%-$48.0M-11.6%-$43.0M-90.7%-$22.5M-470.0%$6.1M-60.7%$15.5M+1540.0%-$1.1M-127.4%$3.9M-74.4%$15.4M-46.5%$28.7M+9450.5%$301K+120.0%-$1.5M+97.1%-$51.6M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

ANIP Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income$24.7M+189.1%$29.5M+88.1%$27.2M+352.5%$26.6M+210.1%$8.5M+473.8%$15.7M-13.9%-$10.8M-881.5%-$24.2M-343.1%-$2.3M-136.6%$18.2M+1165.3%$1.4M+131.7%$9.9M+215.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Ani Pharmaceutic financials

Frequently Asked Questions

What was Ani Pharmaceutic's net income in fiscal year 2025?

Ani Pharmaceutic reported $78.0M in net income in fiscal year 2025.

How fast is Ani Pharmaceutic's net income growing?

Ani Pharmaceutic (ANIP) net income rose by 510.5% year over year, from -$19.0M to $78.0M in fiscal year 2025.

What is Ani Pharmaceutic's net income over the last twelve months?

Ani Pharmaceutic (ANIP) reported $108.0M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Ani Pharmaceutic (ANIP) net income went from -$51.6M in fiscal year 2011 to $78.0M in fiscal year 2025.

Ani Pharmaceutic (ANIP) reported $24.7M in net income in Q2 2026. This represents an increase of 189.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Ani Pharmaceutic (ANIP) reported on that line in every period on record.